A short background: various microfluidic chips functionalized with anti-EpCAM are developed to capture/isolate circulating tumor cells, while one big challenge is that leukocytes are always non-specifically captured to the surface, which will influence the test results.

Can anyone provide any literature reference or own thoughts how this non-specific binding process is happened, and how people are modeling this process?

Any comment is welcome and appreciated. Thanks.